Management of Head & Neck Cancer at Disease Progression: Now What?

Access Course


886437.jpg?interpolation=lanczos-none&resize=300:225Learn to select appropriate therapies while managing treatment side effects to improve outcomes for patients with progression of head and neck cancers.

This activity is intended for hematology/oncology specialists, surgeons, and pathologists.

The goal of this activity is to build healthcare professionals’ confidence in strategies for the individualized treatment of the patient with squamous cell carcinoma of the head and neck (SCCHN) that has progressed despite treatment, and to ensure that best practices are applied across a variety of clinical presentations.



Approximate Time to Complete: 30 minutes


Credit Available: Dec. 20, 2017 - Dec. 20, 2018


Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Course Objectives
Upon completion of this activity, participants will be able to:
  • Demonstrate improved performance associated with prescribing the appropriate regimen for a patient with SCCHN based on patient and tumor characteristics
  • Demonstrate improved performance associated with ordering patient education for expected treatment-related adverse events
Accreditation Council For Continuing Medical Education
AMA PRA Category 1 Credit(s)™: 1.75
American Board of Internal Medicine
ABIM MOC Part 2 Credits: 1.75